1. Home
  2. MREO vs ASA Comparison

MREO vs ASA Comparison

Compare MREO & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

N/A

Current Price

$0.31

Market Cap

50.3M

Sector

Health Care

ML Signal

N/A

ASA

ASA Gold and Precious Metals Limited

N/A

Current Price

$49.15

Market Cap

1.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MREO
ASA
Founded
2015
1958
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
1.0B
IPO Year
2017
2003

Fundamental Metrics

Financial Performance
Metric
MREO
ASA
Price
$0.31
$49.15
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $1.96
N/A
AVG Volume (30 Days)
★ 618.6K
44.9K
Earning Date
11-09-2026
11-30-2026
Dividend Yield
N/A
★ 0.16%
EPS Growth
★ 16.67
N/A
EPS
N/A
★ N/A
Revenue
★ $500,000.00
N/A
Revenue This Year
$59.51
N/A
Revenue Next Year
$2,326.81
N/A
P/E Ratio
★ N/A
$1.96
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$45.79
52 Week High
$2.37
$83.20

Technical Indicators

Market Signals
Indicator
MREO
ASA
Relative Strength Index (RSI) 51.77 43.77
Support Level $0.27 $48.59
Resistance Level $0.35 $52.69
Average True Range (ATR) 0.02 2.22
MACD 0.00 0.24
Stochastic Oscillator 66.05 37.90

Price Performance

Historical Comparison
MREO
ASA

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: